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Background. Individuals at ultra-high risk (UHR) for psychosis show reduced neurocognitive performance across
domains but it is unclear which reductions are associated with transition to frank psychosis. The aim of this study
was to investigate diﬀerences in baseline neurocognitive performance between UHR participants with (UHR-P) and
without transition to psychosis (UHR-NP) and a healthy control (HC) group and examine neurocognitive predictors
of transition over the medium to long term.
Method. A sample of 325 UHR participants recruited consecutively from the Personal Assessment and Crisis
Evaluation (PACE) Clinic in Melbourne and 66 HCs completed a neurocognitive assessment at baseline. The UHR
group was followed up between 2.39 and 14.86 (median=6.45) years later. Cox regression was used to investigate
candidate neurocognitive predictors of psychosis onset.
Results. The UHR group performed more poorly than the HC group across a range of neurocognitive domains but
only performance on digit symbol coding and picture completion diﬀered between the groups. The risk of transition
was only signiﬁcantly associated with poorer performance on visual reproduction [hazard ratio (HR) 0.919, 95%
conﬁdence interval (CI) 0.876–0.965, p=0.001] and matrix reasoning (HR 0.938, 95% CI 0.883–0.996, p=0.037). These
remained signiﬁcant even after controlling for psychopathology at baseline.
Conclusions. This study is the longest follow-up of an UHR sample to date. UHR status was associated with poorer
neurocognitive performance compared to HCs on some tasks. Cognition at identiﬁcation as UHR was not a strong
predictor of risk for transition to psychosis. The results suggests the need to include more experimental paradigms
that isolate discrete cognitive processes to better understand neurocognition at this early stage of illness.
Received 5 July 2012 ; Revised 21 December 2012 ; Accepted 10 January 2013 ; First published online 7 February 2013
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Introduction
Neurocognitive impairment is a common feature
of schizophrenia and is already present at the ﬁrst
episode of psychosis (Mesholam-Gately et al. 2009).
Indeed, decrements in neurocognitive performance
emerge well before the onset of positive psychotic
symptoms. Studies demonstrate that individuals who
later develop schizophrenia show reduced academic
performance and intellectual ability in early childhood
(Cannon et al. 2002) and in adolescence (Reichenberg
et al. 2002).
It is now accepted that individuals at ultra-high risk
(UHR) for psychosis also perform more poorly than
healthy controls (HCs) across a range of neurocog-
nitive domains, with a pattern of impairment similar
to, but less severe than, patients who are already psy-
chotic (Keefe et al. 2006; Eastvold et al. 2007; Giuliano
et al. 2012). Cross-sectional comparisons, however, do
not take into account whether UHR individuals de-
velop psychosis or not. In fact, most young people
identiﬁed as UHR will not develop frank psychosis
(Yung et al. 2004; Cannon et al. 2008; Riecher-Ro¨ssler
et al. 2009; Nelson et al., in press). Lowered neurocog-
nition may therefore reﬂect generalized psychopath-
ology and distress, or other psychiatric illnesses
common in UHR samples (Velthorst et al. 2009), rather
than impairment exclusively associated with an
* Address for correspondence : A. Lin, Ph.D., School of Psychology,
University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
(Email : a.lin@bham.ac.uk)
Psychological Medicine (2013), 43, 2349–2360. f Cambridge University Press 2013
doi:10.1017/S0033291713000123
ORIGINAL ARTICLE
emerging psychotic disorder. Diﬀerences in perform-
ance between UHR samples and non-UHR psychiatric
controls could help to tease out the speciﬁcity of im-
pairment for vulnerability to developing psychosis.
One such study demonstrated that impairments in the
UHR group were most pronounced on visuospatial
tasks (Lindgren et al. 2010). Another study showed
that a UHR sample only diﬀered from non-UHR
clinical controls on visual form perception and per-
ceptual thinking (Ilonen et al. 2010). Although these
two samples diﬀer demographically from most UHR
groups, the ﬁndings suggest that lowered visuospatial
ability may be speciﬁc to the UHR state.
Baseline neurocognitive predictors of progression
from UHR to psychosis have been studied but the ex-
act nature and pattern of impairment remain unclear.
Individuals who transition show poorer overall
neurocognition than those who do not (Keefe et al.
2006; Seidman et al. 2010; Fusar-Poli et al. 2012b ;
Giuliano et al. 2012). Impairment is primarily in the
verbal domain; several studies have identiﬁed lower
vocabulary or verbal IQ (Eastvold et al. 2007; Pukrop
et al. 2007; Seidman et al. 2010; Woodberry et al. 2010;
Giuliano et al. 2012) in the group that developed psy-
chosis. Reduced verbal learning and memory (Brewer
et al. 2005; Lencz et al. 2006; Eastvold et al. 2007;
Pukrop et al. 2007; Kim et al. 2011; Fusar-Poli et al.
2012b ; Giuliano et al. 2012; Simon et al. 2012) and
verbal ﬂuency (Pukrop et al. 2007; Becker et al. 2010;
Kim et al. 2011; Fusar-Poli et al. 2012b) have also been
associated with transition. Poorer performance in the
visual domain is less often reported, with slower pro-
cessing speed on visual tasks (Pukrop et al. 2007;
Riecher-Ro¨ssler et al. 2009) and poorer visual memory
performance (Brewer et al. 2005; Kim et al. 2011)
documented in those who transition in some samples.
It is worth noting that for each of these domains there
are also negative ﬁndings. Additionally, any diﬀer-
ences in cognitive performance are likely to be rel-
atively small, and not valuable for the individual
clinical evaluation of a patient’s risk for transition,
particularly because the proﬁle of impairment is still
poorly understood.
To date, UHR studies have had relatively short
follow-up periods, with few exceptions (Pukrop et al.
2007; Riecher-Ro¨ssler et al. 2009; Seidman et al. 2010;
Kim et al. 2011; Simon et al. 2012). Although transitions
mostly occur within the ﬁrst year, psychosis can de-
velop more than 2 years after identiﬁcation as UHR
(Cannon et al. 2008; Riecher-Ro¨ssler et al. 2009; Nelson
et al., in press). In this respect, short follow-up periods
increase the likelihood of misclassifying true/false
positives. A further limitation of the literature to date
is small sample sizes. Larger studies with longer
follow-up periods are necessary to better characterize
the pattern and magnitude of impairments that rep-
resent vulnerability for psychosis.
In this study, we followed up all UHR research
participants seen at the Personal Assessment
and Crisis Evaluation (PACE) Clinic in Melbourne,
Australia (median follow-up time=6.45 years). The
aims of the study were: (1) to investigate the diﬀerence
in baseline neurocognitive performance between UHR
participants with (UHR-P) and without later transition
to psychosis (UHR-NP) and an HC group; and (2) to
assess baseline neurocognitive candidate predictors of
transition to psychosis in UHR participants.
Performance on tasks of attention, processing
speed, working memory, verbal/visual memory, ver-
bal ﬂuency, reasoning and visuospatial ability was
assessed. We hypothesized that UHR participants
would demonstrate poorer neurocognitive perform-
ance than HC participants across all domains. We ex-
pected poorer performance on verbal abilities and
verbal and visual memory to predict transition to
frank psychosis over the follow-up period.
Method
Sample
The sample consisted of 325 UHR participants (172
females, 153 males) and 66 HCs (27 females, 39 males).
UHR participants were identiﬁed on presentation to
the PACE Clinic between 1993 and 2006 (baseline en-
try into study), and reassessed between 2007 and 2009
(follow-up).
Current data are from participants with baseline
neurocognitive assessment in this large follow-up
study aimed to reassess all participants previously
involved in research at PACE (n=416). HCs (age
range 14–33 years) were recruited through advertise-
ments in technical colleges and job centres, or through
hospital administration staﬀ. All were screened for
psychiatric disorders using the SCID-I Screening
Questionnaire. If they answered ‘yes’ to any item,
that scale of the SCID-I was administered to ensure
they did not meet criteria. An additional exclusion
criterion for HCs was a family history of psychotic
disorder. The performance of a subgroup of these
participants (83 UHR and 37 HC participants) at the
1-year follow-up has been reported previously
(Brewer et al. 2005).
At baseline, UHR participants were aged between
15 and 30 years and met UHR criteria rated on the
Comprehensive Assessment of At-Risk Mental States
(CAARMS; Yung et al. 2005). These are (1) attenuated
psychotic symptoms (APS), (2) brief limited intermit-
tent psychotic symptoms (BLIPS) and/or (3) trait vul-
nerability for psychotic illness (schizotypal personality
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disorder or a history of psychosis in a ﬁrst-degree re-
lative) and deterioration in functioning or chronic low
functioning. These criteria have been operationalized
previously (Yung et al. 2004). Exclusion criteria for
entry into the PACE Clinic (i.e. at baseline) are a
previous psychotic episode (treated or untreated), an
organic cause for presentation or past antipsychotic
exposure equivalent to a total haloperidol dose of
>50 mg.
Inclusion in this study of neurocognition required
participants to have normal (or corrected-to-normal)
vision and hearing, and to speak adequate English.
Exclusion criteria were neurological disorder or a
history of signiﬁcant head injury or seizures. The
subsequent development of an exclusion criterion
resulted in removal from analysis.
Procedure
A previously developed tracking system (Henry et al.
2007) was used to relocate UHR participants. The
sequential algorithm consisted of : (1) PACE research
ﬁles, to gather contact details ; (2) the National Death
Index, to check whether any participants had died
since last contact with PACE; (3) the state of Victoria’s
public mental health service records, which document
contact with public mental health services ; (4) the
Australian national electoral roll ; (5) Australian
telephone directories ; (6) internet-based searching,
including social networking sites ; (7) previous con-
tacts ; and (8) psychiatric medical records.
If UHR participants did not consent to face-to-face
assessment, they were asked for a brief telephone in-
terview or written assessment. Participants not avail-
able for an interview were searched using Victoria’s
public mental health service records. Documented
psychotic disorder in these records was classiﬁed as
transition to psychosis for the purpose of the study.
HC participants were not included in the follow-up
assessment. This study was approved by the local
Research and Ethics Committee. All participants
provided written informed consent.
Measures
Outcome
The main outcome was transition to psychosis,
assessed using the CAARMS (Yung et al. 2005).
Other psychiatric symptoms and functioning
Current or lifetime psychiatric diagnosis was assessed
using SCID-I (First et al. 1997). Symptoms were
assessed using the Brief Psychiatric Rating Scale –
psychotic subscale (BPRS; Overall & Gorham, 1962),
the Scale of Assessment for Negative Symptoms
(SANS; Andreasen, 1982) and the Hamilton De-
pression Rating Scale (HAMD; Hamilton, 1960). The
Global Assessment of Functioning (GAF; APA, 1994)
was used to assess functioning at baseline and follow-
up. Social and Occupational Functioning Assessment
Scale (SOFAS; Goldman et al. 1992) scores also in-
dicated functioning of participants at follow-up.
Candidate neurocognition predictors
A range of potential predictors of transition to psy-
chosis were investigated. Neurocognitive assessment
at baseline varied according to the period during
which participants were recruited (Fig. 1). The fol-
lowing subtests of the Wechsler Adult Intelligence
Scale – Revised (WAIS-R; Wechsler, 1981) were ad-
ministered: information, block design, picture com-
pletion, similarities, digit span, digit symbol coding,
and arithmetic. Alternatively, participants were
administered the full Wechsler Abbreviated Scale
of Intelligence (WASI ; Wechsler, 1999).
Memory was assessed by logical memory I, visual
reproduction I and verbal paired associates I (VPA)
from the Wechsler Memory Scale – Revised (WMS-R;
Wechsler, 1987). The Rey Auditory Verbal Learning
Test (RAVLT; Rey, 1941) was used to assess verbal list
learning and memory. The total score from a three-
trial version of the RAVLT was used in analysis. The
Trail Making Test Parts A and B (TMT-A and TMT-B;
Army Individual Test Battery, 1944) total times were
used to assess psychomotor speed and attention. The
total words generated from the letters F, A and S on
the Controlled Oral Word Association Test (COWAT;
Benton & Hamsher, 1983) provided an index of pho-
nemic verbal ﬂuency. These measures led to a total of
19 candidate predictors to be examined. Higher scores
on all tasks indicate better performance, except on the
TMT where the reverse is true.
Statistical analysis
Statistical analyses were performed using SPSS
version 19 (SPSS Inc., USA). Neurocognitive tasks
were examined individually rather than grouped into
cognitive domains for two reasons. First, it is theor-
etically incorrect to assume that pencil-and-paper
tasks purporting to tap into similar cognitive domains
assess a single cognitive process with a common eﬀect
size (MacDonald & Carter, 2002). Second, grouping
tasks would have resulted in the exclusion of par-
ticipants who did not complete all of the tasks.
Examining each task individually allowed for the
maximum number of participants to be included. Raw
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neurocognitive scores were used in analyses because
some age-scaled scores have a small variance.
Comparison of baseline neurocognitive performance for
UHR and HC participants
To compare neurocognitive performance between the
UHR and HC participants, we used linear regression
with neurocognitive tasks as the response variable
and Group (UHR or HC) as a covariate. Age at base-
line, pre-morbid IQ and gender were also entered
as covariates. F scores and p values for the Group
covariate are reported. Bonferroni correction was
used to adjust for multiple testing (19 performance
variables), meaning that a p value<0.0026 (=0.05/19)
was taken to indicate statistically signiﬁcant evidence
of a diﬀerence at the 5% level. Eﬀect sizes show the
magnitude of diﬀerence and are indicated by Cohen’s
d, calculated from adjusted scores.
Assessment of candidate predictors of transition to
psychosis in UHR participants
Cox proportional hazards regression was used to in-
vestigate the association between measures of neuro-
cognitive performance at baseline (i.e. the candidate
predictors), baseline psychopathology and rate of
transition to known psychosis in the UHR partici-
pants. This method of time-to-event analysis models
the time until a known transition to psychosis. It
includes the follow-up length of each participant until
their transition or until their last time seen without
psychosis. Participants who did not transition were
thus ‘censored’ at their ﬁnal observed follow-up time,
after which they no longer contributed to the analysis.
Such participants might subsequently transition to
psychosis but this was unknown from their available
follow-up data. Cox regression allows the hazard ratio
(HR) to be estimated for each candidate predictor,
which is the ratio of the rate of transition to psychosis
comparing two participants who diﬀer in the predictor
by 1 unit, assuming this ratio is a constant over time.
Analysis was conducted using the following steps :
(1) Baseline neurocognitive variables (candidate pre-
dictors) were each entered in a separate Cox re-
gression and selected if thex2 log likelihood and
Wald statistic were signiﬁcant at p<0.1. The same
process with repeated with psychopathology
variables [BPRS, SANS, HAMD, GAF, and
CAARMS subtests].
(2) Backward multivariable Cox regression analyses
were conducted for psychopathology variables
selected in step 1, and selected again at a signiﬁ-
cance level of p<0.15.
(3) The candidate predictors that were retained
were entered into multivariable backward re-
gression with psychopathology variables as block
1 and neurocognitive variables as block 2. Age at
Baseline recruitment: 1994–1998
Picture completion, digit symbol coding, 
similarities, block design, arithmetic, digit 
span, information (WAIS-R); logical memory I, 
visual reproduction I, VPA I  (WMS-R); RAVLT 
(3 trials); TMT A & B; COWAT.
Baseline recruitment: 2000–2006
Vocabulary, similarities, block design, matrix 
reasoning (WASI)
Baseline recruitment: 1999–2000 
Picture completion, digit symbol coding, 
similarities, arithmetic (WAIS-R);









Fig. 1. The sample during each baseline recruitment period. Not all participants consented or completed every
neurocognitive task ; Tables 2 and 3 show the number of participants assessed on each task. WAIS-R, Wechsler Adult
Intelligence Scale – Revised ; VPA, verbal paired associates ; WMS-R, Wechsler Memory Scale – Revised ; RAVLT, Rey Auditory
Verbal Learning Test ; TMT, Trail Making Test ; COWAT, Controlled Oral Word Association Test ; WASI, Wechsler Abbreviated
Scale of Intelligence ; UHR-P, ultra-high risk participants transitioned to psychosis ; UHR-NP, ultra-high risk participants not
transitioned to psychosis.
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baseline and pre-morbid IQ were included as
covariates with neurocognitive candidate pre-
dictors. The process was repeated forwards to
exclude blocking eﬀects.
Two models were necessary to account for diﬀerences
in tasks administered at diﬀerent recruitment phases.
The ﬁrst (model 1) included participants recruited
from 1994 to 2000. Neurocognitive candidate pre-
dictors included in this model were logical memory I,
RAVLT, VPA, visual reproduction I, COWAT, TMT
(A and B) and all WAIS-R subtests. The second model
(model 2) included all WASI subtests, which were




The demographic characteristics of the UHR (n=325)
and HC (n=66) groups are presented in Table 1. At
follow-up, 246 of the 325 UHR participants (75.7%)
were available for interview [217 (66.7%) face-to-face,
26 (8.0%) telephone, three (0.9%) written]. Thirty-nine
(12%) refused follow-up and 32 (9.8%) could not be
located. Eight participants (2.5%) had died. The mean
age of the UHR cohort at follow-up was 26.04
(S.D.=5.04) years. The follow-up period ranged from
2.39 to 14.86 (mean=7.18, median=6.45) years.
The UHR group were younger (t81=x2.85,
p=0.006) and had lower pre-morbid IQ (t369=x2.17,
p=0.03) than the HCs. Subsequent group analyses
were controlled for age, gender and pre-morbid IQ.
Eighty-one participants (24.9%) were known to
have transitioned to psychosis. The mean time to
transition was 541.07 days (S.D.=660.28 days, me-
dian=1428.00 days). Speciﬁc DSM-IV diagnoses were:
schizophrenia, 28 (8.6%) ; psychotic disorder not
otherwise speciﬁed (NOS), 11 (3.4%) ; major depress-
ive disorder with psychotic features, four (1.2%) ; bi-
polar disorder with psychotic features, four (1.2%);
substance-induced psychotic disorder, four (1.2%);
delusional disorder, one (0.3%) ; brief psychotic dis-
order one (0.3%). Here we report current/lifetime
diagnosis as reported at follow-up assessment (last
known diagnosis) because of known diagnostic vari-
ability early in the illness course (Schwartz et al. 2000).
Participants were asked to report on experiences since
they were last seen at the PACE Clinic, so those in full
remission who had not experienced any psychotic
symptoms since PACE would not rate for speciﬁc di-
agnosis (even though they had previously transitioned
to frank psychosis).
Demographic characteristics for the UHR-P and
UHR-NP groups and statistics for group comparisons
are presented in Table 1. At baseline, the UHR-P
group demonstrated signiﬁcantly higher scores than
UHR-NP on the SANS and the Thought content and
Conceptual disorganization subtests of the CAARMS,
and had lower GAF scores. UHR-P had lower pre-
morbid IQ; subsequent analyses are controlled for pre-
morbid IQ. At the follow-up assessment, UHR-P
showed signiﬁcantly higher scores than UHR-NP on
all measures of psychopathology and lower scores on
measures of functioning.. They were also signiﬁcantly
older and followed up for a longer period of time.
Comparison of baseline neurocognitive performance for
UHR and HC participants
Baseline neurocognitive test scores for UHR and HC
participants are presented in Table 2. On every task
except VPA and COWAT, UHR performed more
poorly than HCs. Medium eﬀect sizes (o0.5) were
evident for (in descending order of size) : digit symbol
coding; vocabulary ; picture completion; logical
memory; block design (WAIS-R) ; matrix reasoning;
TMT-A; TMT-B. After Bonferroni correction, the dif-
ference was statistically signiﬁcant for picture com-
pletion and digit symbol coding only.
Comparison of neurocognitive test performance for UHR-P
and UHR-NP groups
The neurocognitive test scores for the UHR-P and
UHR-NP groups are presented in Table 3. After ad-
justing scores for pre-morbid IQ, age and gender, vis-
ual inspection shows that diﬀerences between the
groups are small. The general pattern is that UHR-P
show lower scores than UHR-NP on tasks of visuos-
patial ability, processing speed and attention, but very
similar or higher scores on tasks of verbal ability and
verbal memory (with the exception of logical memory).
Assessment of candidate predictors of transition to psychosis
in UHR participants
Model 1.When neurocognitive test scores were entered
individually into Cox regressions, only visual repro-
duction and arithmetic demonstrated x2 log likeli-
hood and Wald statistics with a p value <0.1. BPRS
(psychotic subscale), SANS, HAMD, GAF and the
Thought content subscale from the CAARMS all
showed x2 log likelihood and Wald statistics with a
p value <0.1. When these psychopathology variables
were entered into a backward multivariable re-
gression, only GAF remained signiﬁcant at p<0.15.
Next, GAF was entered as block 1 and visual
reproduction, arithmetic, pre-morbid IQ and age at
baseline were entered as block 2 into a multivariable
backward regression. GAF [hazard ratio (HR) 0.951,
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Table 1. Baseline and follow-up characteristics of the ultra-high risk (UHR) and healthy control (HC) groups
Baseline assessment
UHR (n=325) HC (n=66) UHR-P (n=81) UHR-NP (n=244) UHR-P v. UHR-NP
Mean S.D. Mean S.D. Mean S.D. Mean S.D. t df p value
Age (years) 19.13 3.34 20.75 4.36 19.57 3.39 18.99 3.31 1.36 323 0.18
Pre-morbid IQ 101.66 12.67 105.36 11.18 98.77 13.15 102.62 12.38 x2.33 305 0.02
BPRS (psychotic subscale) 9.55 2.88 – – 10.00 3.00 9.40 2.83 1.64 321 0.10
SANS 19.91 12.43 – – 24.12 13.25 18.50 11.85 3.59 322 <0.001
HAMD 19.25 10.03 – – 21.40 10.98 18.34 9.49 2.00 201 0.05
GAF 58.13 11.36 – – 53.31 11.23 59.72 10.97 x4.50 321 <0.001
CAARMS scores – –
Thought content 1.97 1.00 – – 2.38 0.84 1.84 1.01 4.34 320 <0.001
Perceptual abnormalities 2.26 1.38 – – 2.41 1.40 2.22 1.37 1.05 320 0.3
Conceptual disorganization 1.69 1.09 – – 2.05 1.01 1.57 1.09 3.59 139.3 <0.001
n % n % n % n % x2 df p value
Female gender 172 52.9 27 40.9 41 50.6 131 53.7 0.12 1 0.73
Treatment trial at PACE
Risperidonea+CBT 26 8.0 – – 13 16.0 13 5.3 8.10 1 0.004
Risperidoneb+cognitive therapy 37 11.4 – – 7 8.6 30 12.3 0.48 1 0.49
Cognitive therapy+placebo 39 12.0 – – 8 9.9 31 12.7 0.23 1 0.63
Lithiumc 24 7.4 – – 2 2.5 22 9.0 d
Education level
Primary 2 0.6 0 0 0 0 2 0.8 d
Secondary incomplete 195 60.0 31 47.0 54 66.7 141 57.8 1.65 1 0.20
Secondary completed 42 12.9 18 27.3 8 9.9 34 13.9 0.57 1 0.45
Trade or technical training 15 4.6 0 0 5 6.2 10 4.1 0.22 1 0.64
Tertiary 64 19.7 14 21.2 12 14.8 52 21.3 1.24 1 0.27
Postgraduate 4 1.2 3 4.5 1 1.2 3 1.2 d
Missing 3 0.9 0 0 1 1.2 2 0.8 d
Intake groups
APS only 193 59.8 – – 44 54.3 149 61.1 0.75 1 0.39
BLIPS only 18 5.6 – – 8 9.9 35 14.3 0.34 1 0.56
Trait vulnerability only 43 13.3 – – 6 7.4 12 4.9 0.67 1 0.42
APS and BLIPS 19 5.9 – – 6 7.4 13 5.3 0.19 1 0.66
APS and trait vulnerability 43 13.3 – – 15 18.5 28 11.5 2.13 1 0.14
BLIPS and trait vulnerability 3 0.9 – – 0 0 3 1.2 d
All three criteria 4 1.2 – – 1 1.2 3 1.2 d
Missing 2 0.6 1 1.2 1 0.4 d
Follow-up assessment Mean S.D. Mean S.D. Mean S.D. Mean S.D. t df p value
Length of follow-up period (years) 7.18 3.08 – – 8.72 3.02 6.66 2.93 4.72 240 <0.001
Age (years) 26.04 5.04 – – 27.82 5.10 25.43 4.88 3.13 217 0.002
BPRS (psychotic subscale) 6.44 3.43 – – 8.69 4.97 5.67 2.26 4.36 61.8 <0.001
SANS 10.92 13.57 – – 16.22 17.18 9.11 11.61 2.85 71.6 0.006
HAMD 8.88 9.08 – – 13.20 12.12 7.41 7.25 3.35 67.6 0.001
SOFAS 68.45 16.24 – – 58.70 18.56 71.80 13.92 x4.84 77.3 <0.001
GAF 65.33 15.62 – – 55.55 18.03 68.69 13.17 x5.01 76.1 <0.001
CAARMS scores
Unusual thought content 3.22 1.57 4.29 1.38 2.62 1.34 4.49 56 <0.001
Non-bizarre ideas 3.52 1.29 4.42 1.06 3.12 1.18 5.43 105 <0.001
Perceptual abnormalities 3.33 1.31 4.28 1.22 2.99 1.16 5.01 104 <0.001
Disorganized speech 2.37 0.99 2.77 1.21 2.22 0.85 2.48 47.2 0.02
UHR-P, UHR participants who transitioned to psychosis ; UHR-NP, UHR participants who did not transition to psychosis ; BPRS, Brief Psychiatric
Rating Scale (psychotic subscale) ; SANS, Scale of Assessment for Negative Symptoms ; HAMD, Hamilton Depression Rating Scale ; GAF, Global
Assessment of Functioning ; CAARMS, Comprehensive Assessment of the At-risk Mental State ; PACE, Personal Assessment and Crisis Evaluation ;
CBT, cognitive behaviour therapy ; APS, attenuated psychotic symptoms ; BLIPS, brief limited intermittent psychotic symptoms ; SOFAS, Social and
Occupational Functioning Assessment Scale ; S.D., standard deviation ; df, degrees of freedom.
a 1–2 mg daily risperidone for 6 months.
b Up to 2 mg risperidone for 12 months.
c One slow release 450-g tablet of lithium carbonate each night for 3 months.
d x2 was not calculated if the expected cell count was<5.
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95% conﬁdence interval (CI) 0.927–0.977, p<0.001] and
visual reproduction (HR 0.919, 95% CI 0.876–0.965,
p=0.001) remained signiﬁcant at p<0.05. The variables
in the ﬁnal model are presented in Table 4.
Model 2. When scores on the WASI subtest were en-
tered individually into Cox regressions, only matrix
reasoning demonstrated x2 log likelihood and Wald
statistics with a p value <0.1. BPRS (psychotic sub-
scale), SANS, GAF and the Thought content subscale
from the CAARMS all showed x2 log likelihood and
Wald statistics with a p value <0.1. When these psy-
chopathology variables were entering into a backward
multivariable regression, only GAF and Thought con-
tent from the CAARMS remained signiﬁcant at p value
<0.15.
Next, GAF and Thought content were entered as
block 1 and matrix reasoning, pre-morbid IQ and age
at baseline were entered as block 2 into a multivariable
backward regression. Thought content (HR 2.071,
95% CI 1.297–3.308, p=0.002) and matrix reasoning
(HR 0.938, 95% CI 0.883–0.996, p=0.037) remained
signiﬁcant at p<0.05. The variables in the ﬁnal model
are presented in Table 5.
Discussion
In this follow-up study, we investigated the neuro-
cognitive performance of UHR and HC groups, and
the relationship between neurocognition and tran-
sition to psychosis between 2 and 15 years after
identiﬁcation as UHR. At baseline, UHR participants
performed more poorly than HCs across a range of
measures, with tasks of processing speed and visuos-
patial ability consistently showing the largest eﬀect
sizes. However, only performance on digit symbol
coding and picture completion diﬀered signiﬁcantly
between groups. When multivariable analyses were
used to predict transition to psychosis, poorer per-
formance on matrix reasoning and visual repro-
duction were the only signiﬁcant neurocognitive
variables. Although HRs were small, these tasks re-
mained signiﬁcant predictors of transition to psy-
chosis after accounting for baseline psychopathology.
There is a well-established literature demonstrating
that UHR status is associated with impairments across
multiple neurocognitive abilities (for meta-analyses
see Fusar-Poli et al. 2012b ; Giuliano et al. 2012). In the
current sample, UHR participants performed more
poorly than HCs, although only performance on digit
Table 2. Baseline neurocognitive performance of ultra-high risk (UHR) and healthy control (HC) groups
UHR HC
F p value Cohen’s dn Mean S.D. n Mean S.D.
Logical memory I 91 23.93 7.98 37 28.66 8.15 8.62 0.004 0.59
RAVLT (ﬁrst three trials) 95 28.71 5.75 37 29.42 5.90 0.38 0.54 0.12
VPA (related pairs) 124 10.81 1.45 36 10.63 1.44 0.42 0.52 x0.12
VPA (unrelated pairs) 124 7.72 2.56 36 7.71 2.64 0.00 >0.9 0.00
Visual reproduction I 87 34.40 5.22 37 36.05 5.29 2.44 0.12 0.32
Matrix reasoning (WASI) 177 26.00 4.66 27 28.55 4.78 6.65 0.01 0.55
Picture completion (WAIS-R) 124 15.26 2.78 36 17.00 2.88 9.98 0.002 0.62
Block design (WAIS-R) 92 33.16 8.34 34 37.83 8.51 7.30 0.008 0.56
Block design (WASI) 178 46.39 12.54 27 47.52 12.94 0.18 0.68 0.09
Information (WAIS-R) 92 16.57 3.74 36 18.51 3.78 6.48 0.01 0.52
Similarities (WAIS-R) 123 19.08 3.66 36 20.64 3.72 4.84 0.03 0.43
Similarities (WASI) 177 34.00 5.32 27 36.10 5.46 3.42 0.07 0.39
Vocabulary (WASI) 178 50.79 8.27 27 56.23 8.57 9.32 0.003 0.66
COWAT 95 36.49 10.62 37 34.86 10.89 0.58 0.45 x0.15
Arithmetic (WAIS-R) 124 10.09 2.78 36 11.42 2.88 5.85 0.02 0.48
Digit span (WAIS-R) 124 15.23 4.01 36 15.61 4.02 0.24 0.62 0.10
Digit symbol coding (WAIS-R) 127 56.01 9.35 37 62.87 9.55 14.63 <0.001 0.73
TMT-A 94 27.30 8.92 37 22.75 9.12 6.39 0.01 0.51
TMT-B 94 69.48 23.07 37 57.78 23.66 6.33 0.01 0.50
RAVLT, Rey Auditory Verbal Learning Test ; VPA, verbal paired associates ; WASI, Wechsler Abbreviated Scale of
Intelligence ; WAIS-R, Wechsler Adult Intelligence Scale – Revised ; COWAT, Controlled Oral Word Association Test ; TMT-A,
Trail Making Test Part A ; TMT-B, Trail Making Test Part B ; S.D., standard deviation.
Analysis covaried for age, gender and pre-morbid IQ. Adjusted raw scores are reported. Cohen’s d is calculated on adjusted
scores. Higher scores on the TMT indicate poorer performance. The p values signiﬁcant after Bonferroni correction are in bold.
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Table 3. Baseline neurocognitive performance of ultra-high risk participants transitioned
(UHR-P) and not transitioned to psychosis (UHR-NP)
UHR-P UHR-NP
n Mean S.D. n Mean S.D.
Logical memory I 40 22.96 8.41 51 24.03 8.36
RAVLT (ﬁrst three trials) 43 28.48 5.84 52 28.76 5.84
VPA (related pairs) 49 10.85 1.40 75 10.74 1.39
VPA (unrelated pairs) 49 7.80 2.73 75 7.61 2.68
Visual reproduction I 38 32.16 5.18 49 35.26 5.11
Matrix reasoning (WASI) 24 23.38 4.75 153 26.46 4.70
Picture completion (WAIS-R) 50 14.72 3.11 74 15.43 3.10
Block design (WAIS-R) 41 32.36 9.22 51 32.16 9.14
Block design (WASI) 25 44.22 12.85 153 46.65 12.74
Information (WAIS-R) 41 16.50 3.84 51 15.44 3.78
Similarities (WAIS-R) 50 18.84 3.75 73 18.85 3.76
Similarities (WASI) 24 35.06 5.44 153 33.80 5.44
Vocabulary (WASI) 25 51.62 8.70 153 50.50 8.66
COWAT 43 35.53 10.89 52 35.78 10.82
Arithmetic (WAIS-R) 50 9.22 3.00 74 10.26 2.92
Digit span (WAIS-R) 50 14.76 4.03 74 15.11 3.96
Digit symbol coding (WAIS-R) 52 53.93 9.73 75 57.17 9.70
TMT-A 42 28.74 10.17 52 26.87 10.10
TMT-B 42 76.70 25.27 52 66.17 25.09
RAVLT, Rey Auditory Verbal Learning Test ; VPA, verbal paired associates ;
WASI, Wechsler Abbreviated Scale of Intelligence ; WAIS-R, Wechsler Adult
Intelligence Scale – Revised ; COWAT, Controlled Oral Word Association Test ;
TMT-A, Trail Making Test Part A ; TMT-B, Trail Making Test Part B ; S.D., standard
deviation.
Raw scores adjusted for age, gender and pre-morbid IQ are reported. Higher scores
on the TMT indicate poorer performance.
Table 4. Cox proportional hazard model 1
B S.E. HR 95% CI p value
GAF x0.050 0.013 0.951 0.927–0.977 <0.001
Visual reproduction x0.084 0.024 0.919 0.876–0.965 0.001
GAF, Global Assessment of Functioning ; S.E., standard error ; HR, hazard ratio ;
CI, conﬁdence interval.
Table 5. Cox proportional hazard model 2
B S.E. HR 95% CI p value
CAARMS Thought content 0.728 0.239 2.071 1.297–3.308 0.002
Matrix reasoning (WASI) x0.064 0.031 0.938 0.883–0.996 0.037
CAARMS, Comprehensive Assessment of the At-risk Mental State ; WASI,
Wechsler Abbreviated Scale of Intelligence ; S.E., standard error ; HR, hazard
ratio ; CI, conﬁdence interval.
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symbol coding and picture completion reached stat-
istical signiﬁcance after adjusting for multiple com-
parisons, pre-morbid IQ, age and gender. Medium to
large eﬀect sizes were evident on all tasks of proces-
sing speed (TMT-A, TMT-B, digit symbol coding),
with digit symbol coding showing the largest eﬀect of
all tasks administered. Other group diﬀerences with
eﬀects of medium to large magnitude were detected,
although these were not seen consistently across all
tasks in any domain. The ﬁnding of reduced proces-
sing speed is consistent with meta-analytic evidence
that performance on digit symbol coding is the best
discriminator of UHR from HCs (Fusar-Poli et al.
2012b), which is unsurprising given that performance
on this task has been shown to best discriminate in-
dividuals with schizophrenia from HC participants
(Dickinson et al. 2007). However, the lack of a consist-
ent diﬀerence in processing speed when UHR samples
are compared to non-UHR psychiatric controls is
noteworthy (Ilonen et al. 2010; Lindgren et al. 2010),
suggesting that this impairment may not be speciﬁc to
the ‘at-risk ’ state. Instead, slowed processing might
represent a reduction in performance associated with
general psychopathology and distress. From a clinical
point of view, slower processing speed would be ex-
pected in individuals with high levels of depression
and general psychological distress, which are common
in UHR samples (Velthorst et al. 2009).
Notably, there were no signiﬁcant diﬀerences
between the UHR and HC groups on WASI tasks.
These tasks were administered to UHR participants
recruited more recently (2000–2006; see Fig. 1). Un-
fortunately, it was not possible to determine whether
this lack of group diﬀerences was a function of the
tests themselves or the subgroup to which they were
administered. Given the evidence of a decline in tran-
sition rate in recent years (Yung et al. 2007; Simon et al.
2011; Fusar-Poli et al. 2012a), and the suggestion that
the risk status of the sample at PACE has been
‘diluted’ (Yung et al. 2007), the latter seems likely. This
later-recruited subgroup was also less likely to de-
velop psychosis than their earlier-recruited counter-
parts (approximately 14% v. 39%), and, as a group,
could be less cognitively impaired. These individuals
may well be experiencing transient attenuated psy-
chotic symptoms associated with other psychopath-
ology, such as depression. Unfortunately, processing
speed was not measured in this group, making it dif-
ﬁcult to assess the validity of the hypothesis that slo-
wed speed of processing is related to high levels of
distress and general psychopathology.
When neurocognitive variables were entered into
Cox regression to predict psychosis onset, the results
show that they were not strong predictors of tran-
sition. Moreover, against expectations, verbal abilities
and verbal memory were not lower in the UHR-P
group compared to UHR-NP. In the ﬁrst model,
lower visual reproduction, a task of visual memory
and visuospatial ability predicted transition, along
with lower functioning indexed on the GAF. In
model 2, poorer performance on matrix reasoning of
the WASI was associated with increased risk for
transition together with higher scores on the Thought
content subscale of the CAARMS. Examination of
HRs shows that, in real terms, neurocognition
was only a weak predictor of the development of
psychosis.
To date, the literature on neurocognition and
transition to psychosis has been inconsistent. There is
evidence that impairment in verbal abilities is associ-
ated with transition from UHR to psychosis, particu-
larly general vocabulary or verbal IQ (Eastvold et al.
2007; Pukrop et al. 2007; Seidman et al. 2010;
Woodberry et al. 2010), verbal learning and memory
(Brewer et al. 2005; Lencz et al. 2006; Eastvold et al.
2007; Pukrop et al. 2007; Kim et al. 2011) and verbal
ﬂuency (Pukrop et al. 2007; Becker et al. 2010; Kim et al.
2011). We have shown previously that poorer per-
formance on visual reproduction is associated with
transition (Brewer et al. 2005), and here extend that
ﬁnding with the use of Cox regression analyses and a
much longer follow-up period with additional transi-
tioned cases. Importantly, our ﬁndings here suggest
that only visual reproduction performance is asso-
ciated with transition. Visual reproduction ability was
also shown to predict transition in a more recent study
(Kim et al. 2011), and a recent meta-analysis (Fusar-
Poli et al. 2012b) demonstrated that those who
transition do in fact show reduced visual memory.
Similarly, another meta-analysis (Giuliano et al. 2012)
found visuospatial ability to be the fourth largest cog-
nitive deﬁcit in those who transition to psychosis.
Matrix reasoning, which assesses visual abstract ma-
nipulation, has not previously been associated with
transition, although others have shown that matrix
reasoning (Lindgren et al. 2010) and visual form per-
ception (Ilonen et al. 2010) diﬀerentiated UHR subjects
from non-UHR psychiatric controls. This suggests that
impaired visual manipulation might have some
speciﬁcity for vulnerability for psychosis, but more
investigation is needed. Overall, our ﬁndings add little
clarity to our understanding of this literature, except
conﬁrmation that the predictive validity of neurocog-
nitive performance (as assessed using traditional
neuropsychological tasks) is likely to be very weak at
this stage of illness.
The major strength of this study lies in the duration
of follow-up and large sample size. This study re-
presents the longest follow-up of any UHR sample,
providing novel information on neurocognitive
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predictors of psychosis onset. However, only a subset
of participants had comprehensive neurocognitive as-
sessment, which limits the conclusions that can be
drawn. Additionally, some neurocognitive domains
were not assessed. For example, semantic verbal ﬂu-
ency has been shown to predict psychosis (Becker et al.
2010), but this was not measured. It should be noted
that treatment outside the PACE Clinic or since dis-
charge was not controlled. We investigated the pro-
portion of participants who received speciﬁc trial
intervention treatment at the PACE Clinic (cognitive
therapy and placebo; cognitive or cognitive beha-
vioural therapy and low dose antipsychotics ; low dose
lithium). There was a signiﬁcant diﬀerence between
UHR-P and UHR-NP participants in this sample on
one therapeutic regime (risperidone and CBT), which
may have inﬂuenced results.
Future work in this area requires large samples fol-
lowed up for long periods of time. Neurocognitive
decrements at this early stage of psychotic illness
are likely to be small. The current ﬁndings show that,
if impairments do exist, the use of traditional neuro-
psychological tests is unlikely to detect them. Future
studies should include fewer measures of global
neurocognition and more computerized tasks that
target speciﬁc abilities and decompose performance
into discrete processes (MacDonald & Carter, 2002).
These types of experimental paradigms are necessary
to tease out the speciﬁcity of impairments at this stage
of illness and improve our understanding of the tra-
jectory of neurocognitive changes over the develop-
ment of psychosis.
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